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Objective: To analyse the psychometric properties of the EuroQol questionnaire (EQ-5D) applied to
patients with acute coronary syndromes (ACS).
Setting: Rehabilitation hospital.
Patients and design: 106 consecutive patients with ACS (51% myocardial infarction, 42% coronary artery
bypass grafting, 7% angina) completed the EQ-5D, the 36 item short form health survey (SF-36), and the
MacNew questionnaire at admission, at discharge, and three months after inpatient cardiac rehabilitation.
Acceptance, validity, reliability, and responsiveness of the EQ-5D were tested.
Results: The EQ-5D was highly accepted. The EQ-5D index showed substantial ceiling effects after
rehabilitation. As expected the EQ-5D visual analogue scale (VAS) score (70.3 v 57.1) and EQ-5D index
(77.8 v 64.5) were significantly better for patients with myocardial infarction than for patients who
underwent surgery (both p ( 0.001). Significant correlations were found between the EQ-5D VAS score,
EQ-5D index, and domains of the SF-36 (r = 0.21 to r = 0.74). The correlation with the MacNew
subscores and with the global score ranged between 0.55 and 0.78. With repeated measurement the EQ-
5D showed reasonable reliability in stable patients with intraclass correlation ranging between 0.91 and
0.54. EQ-5D was responsive in patients who indicated improvement in health states between admission
and discharge (effect size 0.74–0.82).
Conclusion: The psychometric properties of the EQ-5D were satisfying. It is a reasonably valid, reliable,
and responsive instrument for patients with ACS. It may be useful in clinical research and epidemiological
studies to generate preference based valuations of health related quality life.
A
cute coronary syndromes (ACS) are highly prevalent in
western countries. The diagnosis of ACS is associated
with a high mortality and leads to increased morbidity,
including chronic physical impairments and functional
limitations, all of which have an impact on health related
quality of life (HRQoL). HRQoL is a subjective measure of
well being comprising social, mental, and physical dimen-
sions.1
Instruments used to measure HRQoL can be divided into
generic and disease specific instruments. Generic instru-
ments assess the overall health state and allow comparison of
HRQoL across different health problems. They are therefore
suited to support decision making at the population level.2 In
comparison, disease specific instruments focus on certain
aspects of the disease and are considered to be more sensitive
to health changes.3
Preference based summary scores of HRQoL are increas-
ingly used in medical research and accepted by physicians as
a complementary measure of the medical effectiveness of
interventions.4 5 They are also recognised as a major outcome
in the evaluation of new health technologies, which has a
growing influence on allocation decisions in the health care
sector.6 7
The EuroQol questionnaire (EQ-5D) was developed by an
international task force aiming at creating a simple generic
measure that aggregated HRQoL into a single index.8 In
contrast to summary scores of other HRQoL instruments, the
EQ-5D allows preference based valuation of the health state
with the visual analogue scale (VAS) used for a patient’s
subjective valuation9 and a survey based index reflecting
community preferences.10
The EQ-5D has been used in numerous studies for various
indications, including coronary heart disease.11 12
Validity and reliability of the questionnaire have been
tested for various diseases and for the general population.9
However, to our knowledge, the psychometric properties of
the EQ-5D have not been previously assessed for patients
with ACS. Thus, the goal of the study was to analyse the
psychometric properties (validity, reliability, and responsive-
ness) of the EQ-5D for testing patients after ACS.
METHODS
Patients
For the study, 114 consecutive patients starting inpatient
rehabilitation after an acute cardiac event were recruited at
admission to the Schwabenlandklinik, a rehabilitation
hospital in Southern Germany. Exclusion criteria were age
above 65 years, insufficient command of the German
language, and an acute cardiac event occurring more than
three months before admission to the rehabilitation hospital.
Questionnaires
Patients received a questionnaire at admission, at discharge,
and three months after discharge from rehabilitation. It
consisted of questions on demographic data as well as the
German versions of the EQ-5D, the 36 item short form health
survey (SF-36), and the MacNew questionnaire. The clinic
staff handed out and collected the questionnaire during the
patients’ inpatient stay. The questionnaire three months after
discharge was sent by mail.
Abbreviations: ACS, acute coronary syndromes; EQ-5D, EuroQol
questionnaire; HRQoL, health related quality of life; MI, myocardial
infarction; NYHA, New York Heart Association; SF-36, 36 item short
form health survey; VAS, visual analogue scale
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EQ-5D
The EQ-5D comprises five questions asking for the current
health state in the five dimensions: mobility, self care, usual
activities, pain/discomfort, and anxiety/depression.8 9 13 The
categories of the response offer three levels: no problems
(score of 1), moderate problems (2), and extreme problems
(3). This part is called ‘‘self classifier’’ and provides a five
dimensional description of the health state. Combining the
classifications yields 35 = 243 different health states, which
can be expressed as a five digit number. For example, 11122
indicates no problem in usual activities, mobility, and self
care but moderate problems with pain and anxiety/depres-
sion.
In this study the descriptive part of the questionnaire was
followed by a VAS, a graph representation similar to a
thermometer that ranges from 0 (worst imaginable health
state) to 100 (best imaginable health state).
The questionnaire used at clinic discharge and three
months after discharge also included a transition question,
which asked whether patients felt better, worse, or
unchanged compared with their previous situation (that is,
at admission and at discharge, respectively).
Different approaches can be used for the preference based
valuation of EQ-5D health states. The direct method is to take
the VAS value the patient has attributed to his or her current
health state. An alternative method is based on the EQ-5D
valuation questionnaire. In several countries people in a
sample of the general population were asked to value various
health states defined by the EQ-5D descriptive system. These
preference weights were used to develop national valuation
formulas for all 243 EQ-5D health states.13 14 In a recent study
by the EuroQol group, data from six countries were pooled
and a single European formula was derived that additively
aggregates the five dimensions describing the health state.15
This EQ-5D index based on the European formula has been
used in this study.
Whereas the subjective rating of their own health state on
the VAS reflects the respondents’ personal valuation of their
health state, the EQ-5D index reflects health state valuation
based on general population preferences. Population prefer-
ences become increasingly important in making decisions on
the coverage and reimbursement of new health technologies.
SF-36
The SF-36 is a generic HRQoL questionnaire containing 36
items that are grouped into eight domains measured on a
scale from 0 to 100.16 In the version used in this study items
referred to the week preceding questioning. The SF-36 was
used as a reference instrument, since its psychometric
properties have been tested in the general population and
among patients with ACS and related cardiovascular dis-
eases.17–19 Furthermore, it has been widely used in cardiac
studies and its 36 items cover similar aspects of HRQoL in
more detail. In contrast to the EQ-5D, the SF-36 provides a
purely descriptive measure without a preference based
valuation of the health state. The German version of the
SF-36 has been tested and validated in a general population
sample.20
MacNew HRQoL questionnaire
The MacNew questionnaire is a disease specific instrument
originally designed for measuring quality of life after
myocardial infarction (MI) and has been refined since.21–23
It contains 27 items referring to the preceding two weeks,
which can be combined in one global score. Three subscales
(physical functioning, emotional functioning, and social
functioning) can also be calculated. Scores are normalised
in the range from 1 (poor) to 7 (high). Norm scores for
several patient subgroups with cardiac complaints have been
published recently.24 The SF-36 has been found to be a
sensitive measure compared with other HRQoL instruments
for cardiac interventions.25 The German version of the
MacNew has been successfully validated in a sample of
patients with coronary artery disease.26
Psychometric analysis
Acceptance and feasibility were assessed by the proportion of
missing entries and invalid responses. Ambiguous responses
to the EQ-5D (self classifier) and EQ-5D VAS were rated
invalid.
The ability of the EQ-5D to discriminate between health
states was assessed by searching for a tendency towards a
single level of response as well as ceiling effects. A ceiling
effect means that the instrument is unable to discriminate
between comparatively good health states.
Table 1 Demographic and disease related characteristics
Total sample
(n = 106)
MI
(n = 54)
CABG
(n = 45)
Others*
(n = 7)
Age (years) 55 (7.6) 53.4 (8.5) 56.9 (6.1) 55.4 (8.1)
Range 30–65 30–65 41–65 44–64
Men 90 (85%) 45 (83%) 39 (87%) 6 (86%)
Women 16 (15%) 9 (17%) 6 (13%) 1 (14%)
Vocational education
None 4 (4%) 3 (6%) 1 (2%) 0
Vocational training 52 (49%) 25 (46%) 22 (49%) 5 (71%)
Technical school 23 (22%) 14 (26%) 8 (18%) 1 (14%)
University/technical college 21 (20%) 8 (15%) 12 (27%) 1 (14%)
Others/NA 6 (6%) 4 (7%) 2 (4%) 0
NYHA class
I 88 (83%) 48 (89%) 35 (78%) 5 (71%)
II 10 (9%) 5 (9%) 4 (9%) 1 (14%)
III 3 (3%) 0 3 (7%) 0
IV 0 0 0 0
NA 5 (5%) 1 (2%) 3 (7%) 1 (14%)
Disease duration (months) 20.6 (47.7) 11.7 (42.2) 33.6 (54.4) 5.1 (8.5)
Range 0.5–264 0.5–264 0.5–192 1.0–24
Data are mean (SD) or number (%).
*Angina (n = 5), unspecified cardiac insufficiency (n = 2).
CABG, coronary artery bypass graft surgery; MI, myocardial infarction; NA, not available; NYHA, New York
Heart Association.
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To assess construct validity of the EQ-5D several hypoth-
esis were tested. Firstly, we hypothesised that the EQ-5D VAS
and EQ-5D index score correlate positively with physical
capacity measured by the peak load in ergometric exercise.
Secondly, we hypothesised that the level of response to the
EQ-5D self classifier and the EQ-5D VAS score and the EQ-5D
index indicate better HRQoL for patients after MI than for
patients after coronary artery bypass graft surgery (CABG).
We intended to compare EQ-5D scores across New York Heart
Association (NYHA) classes; however, owing to the unba-
lanced distribution of patients in NYHA classes, a meaningful
comparison was not possible.
Criterion validity was tested by comparing EQ-5D response
with the corresponding scores of the SF-36 and MacNew
questionnaire. With respect to the EQ-5D self classifier we
analysed the association between response level and the
median scores of the SF-36 and MacNew. For the EQ-5D VAS
score and EQ-5D index, correlation coefficients with the SF-
36 subscales and MacNew scores were calculated.
To assess test-retest reliability of the subjective health
state, consecutive measurements of EQ-5D self classifier and
the EQ-5D VAS score were compared for the subsample of
patients who indicated in the transition question that HRQoL
remained unchanged.
Sensitivity to change was assessed by analysing the change
in EQ-5D VAS scores and EQ-5D index of patients indicating
in the transition question improvement in health within
period 1 (admission to discharge) and period 2 (discharge to
three months’ follow up). In addition, effect sizes were
calculated for scores of EQ-5D VAS and EQ-5D index by
means of the standard deviation at baseline for normalising
the mean difference.27
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Figure 1 Distribution of responses to items of the EuroQol questionnaire (EQ-5D) self classifier. Data are from questionnaires from 88 patients for
whom all three surveys (admission, discharge, three months’ follow up (FU)) were available.
Table 2 Construct validity: comparison of EuroQol
questionnaire (EQ-5D) results between subgroups at
admission
Diagnosis
p ValueMI CABG
EQ-5D dimension
Mobility n = 54 n =44
No problems 44 (81.5%) 27 (61.4%)
Moderate problems 10 (18.5%) 17 (38.6%)
Extreme problems 0 0 0.03*
Self care n = 54 n =44
No problems 54 (100%) 34 (77.3%)
Moderate problems 0 10 (22.7%)
Extreme problems 0 0 ,0.001
Usual activities n = 52 n =43
No problems 29 (55.8%) 11 (25.6%)
Moderate problems 19 (36.5%) 22 (51.2%)
Extreme problems 4 (7.7%) 10 (23.2%) 0.006`
Pain n = 54 n =44
No problems 28 (51.9%) 7 (15.9%)
Moderate problems 26 (48.1%) 35 (79.5%)
Extreme problems 0 2 0.002*
Anxiety/depression n = 54 n =44
No problems 27 (50.0%) 23 (52.3%)
Moderate problems 25 (46.3%) 20 (45.5%)
Extreme problems 2 (3.7%) 1 (2.3%) 0.82*
VAS n =51 n =44
Median 70.0 60
Mean 70.3 57.1 ,0.0011
EQ-5D index n = 52 N=43
Median 79.5 71.3
Mean 77.8 64.5 0.0011
*x2 test with the categories moderate and extreme collapsed into one
category; Fisher’s exact test due to small expected cell counts; `x2 test;
1Student’s t test.
VAS, visual analogue scale.
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Calculations and statistical analysis were performed with
the software package SAS 8.02 (SAS Institute, Cary, North
Carolina, USA).
RESULTS
Of 114 patients who where recruited into the trial, eight were
excluded from the analysis: five patients withdrew their
informed consent for various reasons and three patients had
incomplete documentation because of administrative rea-
sons. Thus, the size of the valid sample was 106. Of these
participants, 54 (51%) had an MI and 45 (42%) underwent
CABG. With the exception of disease duration, patient
characteristics were comparable across diagnosis groups
(table 1).
Acceptance and feasibility
The percentage of missing and invalid responses in the EQ-
5D self classifier ranged from 0.6% (admission) to 2.9%
(discharge). For the VAS it ranged from 2.2% to 4.8% and for
the SF-36, from 1.5% (three months) to 6.5% (discharge). For
the MacNew questionnaire, from 1.5% to 2.3% had invalid
answers. The majority of the participants rated the EQ-5D as
easy or very easy to fill in, ranging from 78% (admission) to
85% (discharge) at all three times of completion.
Discriminative ability
Respondents indicated problems in the dimensions usual
activities, pain, and anxiety/depression, whereas the dimen-
sions mobility and self care were less affected (fig 1). At
admission, the 10 most frequent combinations of the self
classifier accounted for 75% of all answers, although these
combinations amounted to just 4.1% of all possible combina-
tions. At discharge and after three months, this percentage
increased to around 90% with the best possible health state
(11111) accounting for 42% and 43%, respectively, whereas at
admission this health state was indicated by 15%. Thus, the
ceiling effect for the EQ-5D self classifier was substantial.
Since the EQ-5D index is calculated based on the classifier its
behaviour in terms of ceiling effect is comparable: at
admission 15% had values in the top 10% of the scale scoring
within the interval 91 to 100 and 42% at the three months.
For the VAS the respective proportions were 4% at admission
and just 16% three months after discharge.
Construct validity
Correlation between the EQ-5D VAS score and peak
performance on the ergometer was 0.34 (p , 0.001) and
0.28 (p = 0.006) for the EQ-5D index. We further hypothe-
sised that because of postsurgical complaints HRQoL at
admission for patients after bypass surgery is lower than for
patients who have had an MI. Comparison of the EQ-5D self
classifier showed that with the exception of the dimension
anxiety/depression, the percentage of patients citing no
problems was significantly higher among patients with MI
than among patients after surgery (table 2).
For the EQ-5D VAS and the EQ-5D index, mean scores
were significantly better for the MI group than for patients
after CABG (p ( 0.001).
Criterion validity
Table 3 shows the median scores of SF-36 and MacNew
subscales at admission. For all EQ-5D items the median of
the subscales of SF-36 and MacNew were ranked as expected
and significantly different between groups. With the excep-
tion of the subscale role limitations caused by emotional
problems, the correlation coefficients between SF-36 sub-
scales and the EQ-5D index score were . 0.5 at all three time
points (range 0.57–0.74) (table 4). The correlation of EQ-5D
index with the MacNew global score ranged from 0.69
(admission) to 0.78 (at three months). The pattern of
correlation of SF-36 and MacNew with the EQ-5D VAS score
was similar but mostly lower, ranging from 0.21–0.72.
Table 3 Association between the 36 item short form health survey (SF-36) and MacNew subscales and EQ-5D item by
response level at admission
EQ-5D dimension SF-36 subscale MacNew p Value*
Mobility Physical functioning (0–100) Physical functioning (1–7)
No problems 70.0 (25.0) 4.5 (1.9)
Moderate problems 40.0 (35) 3.5 (1.5)
Extreme problems ,0.001
Self care Physical functioning (0–100) Subscale physical functioning (1–7)
No problems 65.0 (30) 4.1 (1.9)
Moderate problems 20.8 (25) 2.8 (1.0)
Extreme problems ,0.001
Usual activities Subscale role limitations (0–100) Subscale physical functioning (1–7)
No problems 25 (75.0) 4.8 (1.9)
Moderate problems 0 (25.0) 3.9 (1.2)
Extreme problems 0 (0) 3.1 (1.2) ,0.001
Usual activities Subscale social functioning (0–100) Subscale social functioning (1–7)
No problems 87.5 (37.5) 5.0 (1.7)
Moderate problems 62.5 (25.5) 4.1 (1.3)
Extreme problems 37.5 (37.5) 3.2 (1.2) ,0.001
Pain Subscale pain (0–100) Subscale physical functioning (1–7)
No problems 100.0 (26.0) 5.1 (1.6)
Moderate problems 42.0 (31.0) 3.8 (1.0)
Extreme problems 17.0 (10.0) 2.5 (1.0) ,0.001
Pain Item chest pain (1–7)
No problems 7.0 (1.0)
Moderate problems 4.0 (2.0)
Extreme problems 2.0 (2.0) ,0.001
Anxiety/depression Subscale mental health (0–100) Subscale emotional functioning (1–7)
No problems 84.0 (20.0) 5.4 (1.2)
Moderate problems 52.0 (24.0) 3.9 (1.4)
Extreme problems 28.0 (8.0) 2.3 (0.6) ,0.001
Data are median (interquartile range).
Owing to missing values comparisons were based on different sample sizes varying between 101 and 104.
*Kruskal-Wallis H test; categories moderate problems and extreme problems were collapsed into one category for significance test.
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Reliabili ty
Of 106 patients, 11 reported no change between admission
and discharge (period 1). Between discharge and three
months’ follow up (period 2), 34 patients indicated that
‘‘by and large’’ their health state had not changed. Table 5
shows the rate of agreement and k statistics of the responses
between admission and discharge and between discharge
and three months’ follow up. The rate of agreement in EQ-5D
self classifier items ranged from 55% to 100% in the first
period and 65% to 97% in the second period. The mean rate of
agreement was 82% in period 1 and 78% in period 2.
Intraclass correlation for the EQ-5D VAS score was 0.82 in
period 1 and 0.80 in period 2 and for the EQ-5D index was
0.91 in period 1 and 0.54 in period 2.
Responsiveness
The effect size was calculated for the group of patients with
improved health states, since in each period the number of
people experiencing deterioration in health state was too low
for analysis. The effect size in both periods was higher for the
EQ-5D VAS (0.82 for period 1, 0.4 for period 2) than for the
EQ-5D index (0.74 for period 1, 0.09 for period 2).
DISCUSSION
Although the EQ-5D has been previously used for patients
with ACS,11 12 to our knowledge its psychometric properties
have not yet been tested for ACS patients.
The low proportion of missing and invalid entries for the
EQ-5D self classifier as well as for the EQ-5D VAS shows that
the instrument is well understood and accepted by patients
with ACS. This is supported by the low proportion of patients
who found it difficult or very difficult to fill in the
questionnaire. Compared with the SF-36, the EQ-5D did
not present problems when patients were hospitalised, as is
shown by the low missing rates at discharge. This also makes
the EQ-5D attractive for use in studies in an inpatient setting.
In contrast with the EQ-5D VAS score, the EQ-5D self
classifier and the EQ-5D index showed substantial ceiling
effects at discharge and three months after rehabilitation. At
these time points, the proportions of patients who described
their health state as the best possible (11111) were 42% and
43%, respectively, which equals the result found in a survey
of the general population.13 This indicates that the EQ-5D
may not discriminate between health states. It may also
indicate that the patients after rehabilitation were indeed
only minimally affected by ACS. This is supported by the
results of the MacNew questionnaire: the global scores at
admission and three months after discharge were 5.51 and
5.41, respectively, for the total sample and were therefore
higher than the mean values of a reference sample of patients
3–5 months after an MI.24 This result also shows the state
dependence of subjective health measures. A healthy person
may hesitate to rate any health state perfect given the
experience of a life threatening ACS just a few weeks earlier.
Construct validity measures the extent to which the
instrument is compatible with prediction deduced from
established theories. We assumed that HRQoL is positively
correlated with physical ability measured by ergometer
exercise. Furthermore, we assumed that owing to postsurgi-
cal complaints, patients after CABG report lower HRQoL than
do patients after MI. The results confirm both hypotheses.
The correlation with ergometer exercise was positive and
significantly different from zero. The relatively low value of
the correlation may be explained by the fact that physical
functioning is just one dimension of HRQoL and ergometer
Table 4 Spearman rank correlations of EQ-5D VAS score and EQ-5D index with subscales of SF-36 and MacNew
Admission Discharge 3 Months
VAS score EQ-5D index VAS score EQ-5D index VAS score EQ-5D index
SF-36 subscales
General health perception 0.61 0.60 0.58 0.61 0.69 0.63
Physical functioning 0.68 0.74 0.71 0.71 0.71 0.74
Social functioning 0.61 0.68 0.49 0.57 0.55 0.63
Pain 0.57 0.63 0.67 0.73 0.61 0.74
Vitality 0.54 0.65 0.63 0.71 0.60 0.72
Role limitations (physical problems) 0.50 0.57 0.57 0.58 0.67 0.72
Mental health 0.46 0.57 0.46 0.58 0.49 0.62
Role limitations (emotional problems) 0.21 0.30 0.33 0.38 0.32 0.35
MacNew
Global score 0.63 0.69 0.63 0.71 0.68 0.78
Subscale social functioning 0.59 0.65 0.61 0.68 0.65 0.74
Subscale emotional functioning 0.55 0.62 0.52 0.62 0.60 0.67
Subscale physical functioning 0.68 0.70 0.68 0.74 0.72 0.82
Owing to missing values comparisons were based on different sample sizes varying between 81 and 99. All coefficients significantly different from zero, p,0.01.
Table 5 Test-retest reliability of EQ-5D, patients with stable health state
Period 1: admission to discharge Period 2: discharge to 3 months
No Proportion of agreement k* No Proportion of agreement k*
EQ-5D dimension
Mobility 11 8 (73%) 0.24 33 29 (88%) 0.53
Self care 11 11 (100%) 1.0 34 33(97%) NA
Usual activities 11 6 (55%) 0.17 33 23 (70%) 0.39
Pain 11 9 (82%) 0.62 32 22 (69%) 0.43
Anxiety/depression 11 11 (100%) 1.0 34 22 (65%) 0.24
n Mean difference (SD) test-retest ICC n Mean difference (SD) test-retest ICC
VAS 10 3.5 (9.1) 0.82 33 4.6 10.1) 0.80
EQ 5D index 11 21.8 (6.4) 0.91 30 0.56 (14.7) 0.54
*Owing to small cell sizes categories 2 and 3 were collapsed; owing to unequal number of rows and columns k could not be calculated.
ICC, intraclass correlation.
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exercise is not expected to correlate strongly with dimensions
of social or mental well being.
Comparison of EQ-5D response with comparable items and
subscale scores of SF-36 and MacNew showed reasonable
criterion validity: the EQ-5D index correlated well with seven
of eight of the SF-36 health domains, as well as with the
MacNew global score and subscores. Although both EQ-5D
scores correlate only moderately with the narrowly defined
SF-36 subscale role functioning due to emotional problems,
which is based on three items, they correlate well with the
broader MacNew subscale emotional functioning, combining
14 items.
Furthermore, whereas the EQ-5D asks about the current
health state, SF-36 and MacNew have different reference
periods. In a relatively dynamic phase of a disease, as is the
case for patients with ACS, this may lead to differences in the
comparative assessment of changes.
The test-retest reliability of the EQ-5D self classifier was
good. The intraclass correlations for stable patients in period
1 are similar to those found for stable patients with stroke.28
Intraclass correlation for period 2 particularly for the EQ-5D
index were lower. This may be due to the relatively long time
of three months between test and retest, which is also longer
than the time spans that are recommended in general.27 29
The good test-retest reliability, especially of the EQ-5D self
classifier and EQ-5D index, may be partly due to the ceiling
effect, since for patients indicating a health state of 11111,
divergence to a better health state is not possible. Some
evidence for this effect is provided by an analysis within
period 2 excluding patients indicating 11111 at baseline. This
analysis produced almost stable intraclass correlations for the
EQ-5D VAS score (0.79) and lower intraclass correlation for
the EQ-5D index (0.46).
An assessment of the responsiveness of the EQ-5D for the
subsample of 81 patients reporting an improvement between
admission and discharge measured an effect size of 0.82 for
the EQ-5D VAS and 0.74 for EQ-5D index. According to
Cohen,30 these effect sizes can be classified as medium to
large effects; they are, however, lower than the respective
effect size of the MacNew global score (1.06). The effect sizes
for the second period were considerably smaller with the EQ-
5D VAS similarly being more responsive than the EQ-5D
index.
Conclusion
The results of this study indicate that the EQ-5D has good
practicability and satisfactory validity and reliability when
applied to patients with ACS. The EQ-5D can be used to
generate preference based valuations of HRQoL. Since the
EQ-5D, consisting of the self classifier and EQ-5D VAS, is
very easy to administer in a very short time, it is reasonable to
use the questionnaire whenever the general HRQoL is
considered to be an important outcome. It may be useful in
clinical research and epidemiological studies to generate
preference based valuations of HRQoL. Showing overall
reasonable psychometric properties the EQ-5D index based
on the European formula may be attractive in multinational
studies. However, the nature of the EQ-5D as a generic
HRQoL instrument inevitably limits its coverage in more
detail of aspects of HRQoL considered relevant to a specific
disease such as depression or anxiety after ACS. Therefore,
the complementary use of a more detailed instrument should
be considered.
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